Hjem › Livmorhalskreft › California

Kliniske studier for Livmorhalskreft i California

38 studier for Livmorhalskreft søker deltakere på steder i California.

Byer i California

Offisiell studietekst (engelsk)

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
og 10 flere

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

DESTINY-PANTUMOUR04

Research Site, San Diego

RekruttererObservasjonsstudie

Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte

RekruttererFase 4

Alder 18 og eldre · Kvinner · Oppdatert 25. sep. 2026 · NCT06952660

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5037), Irvine
University of California Irvine Medical Center ( Site 6006), Orange

RekruttererFase 3

Alder 18 og eldre · Kvinner · Oppdatert 25. sep. 2026 · NCT07216703

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07229313

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Beverly Hills Cancer Center, Beverly Hills
City of Hope Cancer Center, Duarte
University of California Irvine Medical Center, Orange
og 1 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Duarte
City of Hope, Irvine, Irvine

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
og 1 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06400472

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

UC San Diego Moores Cancer Center, San Diego

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07227168

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

University of California at Los Angeles, Los Angeles

Rekrutterer

Alder 18 og eldre · Kvinner · Oppdatert 20. aug. 2026 · NCT06538337

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

City of Hope at Arcadia, Arcadia
City of Hope Medical Center, Duarte
City of Hope at Seacliff, Huntington Beach
og 8 flere

Rekrutterer

Alder 18 og eldre · Kvinner · Oppdatert 10. aug. 2026 · NCT07741968

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06330064

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

City of Hope, Duarte
University of California San Diego Medical Center, Encinitas
City of Hope Orange County Lennar Foundation Cancer, Irvine
og 9 flere

Rekrutterer

Alder 18 og eldre · Kvinner · Oppdatert 30. jul. 2026 · NCT04831580

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

START Los Angeles, Los Angeles

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07524322

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Chao Family Comprehensive Cancer Center University of California, Irvine, Orange

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07064018

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ellison Clinic at Saint John's, Los Angeles
UCSF Medical Center at Mission Bay, San Francisco

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Providence Medical Foundation, Anaheim
Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
og 7 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

KP Southern California - Department of Research & Evaluation, Pasadena

Rekrutterer

Alder 21 til 45 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT07406087

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT06993844

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Stanford University, Palo Alto

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT07022470

A Study of VET3-TGI in Patients With Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles
UC Irvine Health, Orange

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 7. apr. 2026 · NCT06444815

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

UC San Diego, La Jolla

Rekrutterer

Alder 25 til 64 · Kvinner · Oppdatert 10. feb. 2026 · NCT06128304

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

City of Hope, Duarte

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California, Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 11. des. 2025 · NCT06943521

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 125, Los Angeles
Research Site 133, Los Angeles
Research Site 103, Los Angeles
og 1 flere

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 21. nov. 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
og 3 flere

RekruttererObservasjonsstudie

Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Cedars Sinai Medical Center, Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2025 · NCT05941507

A Study of NX-1607 in Adults With Advanced Malignancies

University of Southern California, Los Angeles
University of California, San Francisco, San Francisco

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT05107674

Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

University of California San Diego, La Jolla

RekruttererObservasjonsstudie

Alder 18 og eldre · Kvinner · Oppdatert 13. aug. 2025 · NCT07121543

A Beta-only IL-2 ImmunoTherapY Study

Sharp Memorial Hospital, San Diego
Providence Saint John's Health Center, Santa Monica

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 9. jul. 2025 · NCT05086692

A Multicenter Cancer Biospecimen Collection Study

Curebase, San Francisco

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 12. mar. 2025 · NCT04510129

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.